Derrick S Katayama
age ~53
from Timnath, CO
- Also known as:
-
- Derrick S Katayana
- Derrick Katayama Spencer
- Derrick A
- Phone and address:
- 6773 Flintlock Rd, Timnath, CO 80547
Derrick Katayama Phones & Addresses
- 6773 Flintlock Rd, Timnath, CO 80547
- Fort Collins, CO
- San Jose, CA
- 8775 Costa Verde Blvd, San Diego, CA 92122 • 858 784-0314
- 3717 Nobel Dr, San Diego, CA 92122 • 858 784-0314
- 7150 Shoreline Dr, San Diego, CA 92122 • 858 784-0314
- 1140 Colorado Ave, Denver, CO 80206 • 303 320-5370
- 12560 Colorado Ave, Denver, CO 80241 • 303 331-8068
- Wheat Ridge, CO
- 1140 Colorado Blvd APT 603, Denver, CO 80206
Work
-
Company:Legacy biodesignJun 2015
-
Position:Scientist
Education
-
School / High School:University of Colorado Anschutz Medical Campus2000 to 2006
Skills
Protein Formulation • Protein Chemistry • Vaccine Formulation • Protein Biophysical Characterization • Formulation • Biophysics • Vaccines • Protein Folding • Hplc • Circular Dichroism • Lyophilization • Lc Ms • Mass Spectrometry • Drug Delivery • Biochemistry • Peptides • Biotechnology • Characterization • Drug Development • Dls • Biopharmaceuticals • Laboratory • Pharmaceutics • Toxicology • Chromatography • Drug Discovery • Purification • Glp • Assay Development • Uv/Vis • Antibodies
Industries
Biotechnology
Us Patents
-
Stable Intranasal Formulations Of Carbetocin
view source -
US Patent:20200353029, Nov 12, 2020
-
Filed:Jul 24, 2020
-
Appl. No.:16/938257
-
Inventors:- Skokie IL, US
Ryan E. Holcomb - Fort Collins CO, US
Derrick S. Katayama - Timnath CO, US
Christopher Bryant - Burr Ridge IL, US
Sara Cotter - Wilmette IL, US
Joseph William Cormier - Bethesda MD, US -
Assignee:Levo Therapeutics, Inc. - Skokie IL
-
International Classification:A61K 38/095
A61K 47/38
A61K 47/55
A61K 9/00
A61K 9/08 -
Abstract:The application describes stable aqueous compositions comprising relatively high concentrations of carbetocin and a solubilizer and/or surface active agent. The disclosed carbetocin compositions are effective in the treatment of a neurodevelopmental disorder, such as Präder-Willi syndrome. Additionally, the disclosed carbetocin compositions show improved stability at room temperature and/or under accelerated conditions of stress.
-
Anti-Il-36R Antibody Formulations
view source -
US Patent:20200282053, Sep 10, 2020
-
Filed:Mar 5, 2020
-
Appl. No.:16/809606
-
Inventors:- Ingelheim am Rhein, DE
Anna Maria STEINER - Eberhardzell, DE
Derrick Spencer KATAYAMA - Timnath CO, US
Rajni Prasad MEHRA - Pleasanton CA, US
Ingo Michael PRESSER - Biberach an der Riss, DE
Ravija SINGH - Fremont CA, US
Sara Kay WRIGHT - Castro Valley CA, US -
International Classification:A61K 39/395
C07K 16/24
A61K 47/26
A61K 47/34
A61K 9/00
A61K 47/14
A61K 47/18
A61K 9/19 -
Abstract:The present invention relates to anti-IL-36R formulations for administration to a subject.
-
Stable Intranasal Formulations Of Carbetocin
view source -
US Patent:20200093884, Mar 26, 2020
-
Filed:Sep 20, 2019
-
Appl. No.:16/576940
-
Inventors:Mark C. MANNING - Johnstown CO, US
Ryan E. Holcomb - Fort Collins CO, US
Derrick S. Katayama - Timnath CO, US
Christopher Bryant - Burr Ridge IL, US -
International Classification:A61K 38/095
A61K 47/38
A61K 9/08
A61K 9/00
A61K 47/55 -
Abstract:The application describes stable aqueous compositions comprising relatively high concentrations of carbetocin and a solubilizer and/or surface active agent. The disclosed carbetocin compositions are effective in the treatment of a neurodevelopmental disorder, such as Präder-Willi syndrome. Additionally, the disclosed carbetocin compositions show improved stability at room temperature and/or under accelerated conditions of stress.
License Records
Derrick Spencer Katayama
Address:
1140 Colorado Blvd #603, Denver, CO 80206
License #:
98159 - Expired
Issued Date:
Jul 15, 1998
Renew Date:
Aug 31, 1999
Expiration Date:
Aug 31, 1999
Type:
Pharmacist Intern
Resumes
Scientist
view sourceLocation:
Fremont, CA
Industry:
Biotechnology
Work:
Legacy Biodesign
Scientist
Boehringer Ingelheim Jan 2013 - May 2015
Senior Scientist
Medimmune Nov 2011 - Oct 2012
Scientist
Amylin Pharmaceuticals Jan 2006 - Nov 2011
Senior Scientist
University of Colorado Health Sciences Center 2000 - Jan 2006
Graduate Student
Scientist
Boehringer Ingelheim Jan 2013 - May 2015
Senior Scientist
Medimmune Nov 2011 - Oct 2012
Scientist
Amylin Pharmaceuticals Jan 2006 - Nov 2011
Senior Scientist
University of Colorado Health Sciences Center 2000 - Jan 2006
Graduate Student
Education:
University of Colorado Anschutz Medical Campus 2000 - 2006
Skills:
Protein Formulation
Protein Chemistry
Vaccine Formulation
Protein Biophysical Characterization
Formulation
Biophysics
Vaccines
Protein Folding
Hplc
Circular Dichroism
Lyophilization
Lc Ms
Mass Spectrometry
Drug Delivery
Biochemistry
Peptides
Biotechnology
Characterization
Drug Development
Dls
Biopharmaceuticals
Laboratory
Pharmaceutics
Toxicology
Chromatography
Drug Discovery
Purification
Glp
Assay Development
Uv/Vis
Antibodies
Protein Chemistry
Vaccine Formulation
Protein Biophysical Characterization
Formulation
Biophysics
Vaccines
Protein Folding
Hplc
Circular Dichroism
Lyophilization
Lc Ms
Mass Spectrometry
Drug Delivery
Biochemistry
Peptides
Biotechnology
Characterization
Drug Development
Dls
Biopharmaceuticals
Laboratory
Pharmaceutics
Toxicology
Chromatography
Drug Discovery
Purification
Glp
Assay Development
Uv/Vis
Antibodies
Plaxo
Derrick Katayama's Public
view sourceDerrick Katayama's Public Profile on Plaxo. Plaxo helps members like Derrick Katayama keep in touch with the people who really matter, helping them to connect, keep each other's ...
Youtube
Derrick Katayama
view sourceFriends:
Heidi Balis, Jane Tanigawa Sogge, Phil Richman, John Ahn, John LaGuardia
Get Report for Derrick S Katayama from Timnath, CO, age ~53